Search

Search Constraints

You searched for: Author/Creator Anand, Aseem

Search Results

1. Clinical Validity of Detecting Circulating Tumor Cells by AdnaTest Assay Compared With Direct Detection of Tumor mRNA in Stabilized Whole Blood, as a Biomarker Predicting Overall Survival for Metastatic Castration-Resistant Prostate Cancer Patients. Issue 5 (September 2016)

2. Patterns of response and progression in bone and soft tissue during and after treatment with radium‐223 for metastatic castrate‐resistant prostate cancer. Issue 10 (2nd May 2019)

3. PD35-04 QUANTITATIVE PIFLUFOLASTAT F18 (PSMA) SCAN INDICES AS A RESPONSE IMAGING-BIOMARKER TO ANDROGEN DEPRIVATION THERAPY IN VETERANS WITH NEWLY DIAGNOSED METASTATIC PROSTATE CANCER. (1st May 2022)

4. Serum prolactin level as a predictive factor for abiraterone response in patients with metastatic castration‐resistant prostate cancer. Issue 13 (23rd June 2022)

6. Quantitative Time-Resolved Fluorescence Imaging of Androgen Receptor and Prostate-Specific Antigen in Prostate Tissue Sections. (May 2016)

7. Everolimus combined with gefitinib in patients with metastatic castration‐resistant prostate cancer: Phase 1/2 results and signaling pathway implications. Issue 21 (15th July 2015)

9. Clinical Correlates of Benefit From Radium‐223 Therapy in Metastatic Castration Resistant Prostate Cancer. Issue 5 (19th December 2016)